MedicarePartD.guide

A non-government resource built from CMS public data

Methylphenidate on SilverScript Choice (S5601-022)

Covered.

Tier 3 (preferred brand). Quantity limit of 90 per 30 days.

$5.96
Patient pays / month, after deductible
$33.09
Patient pays / month, before the $615.00 deductible
$17.87
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $33.09 for a month. Other covered strengths are listed below.

All 8 covered strengths and forms
FormTierPatient pays / monthLimits
METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet3$6.5890 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet, Extended Release4$13.5690 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 20 mg Capsule, Extended Release4$90.1930 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet3$5.9690 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet, Extended Release4$31.8490 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 30 mg Capsule, Extended Release4$148.2960 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 40 mg Capsule, Extended Release4$17.8630 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet3$6.4990 per 30 days

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-022